-
Uncategorized2 months agoNeuroblastoma Tumor Growth in Mice Suppressed by Blocking Enzyme to Inhibit mTOR Signaling
Neuroblastoma is the most common tumor among children under a year of age, and while in its gentlest form neuroblastoma can regress on its own, it...
-
Uncategorized2 months agoSmart contact lens monitors eye pressure and delivers glaucoma drugs in early tests
Glaucoma is the second-leading cause of blindness, and a silent one at that. It’s estimated that half of the patients who develop it are unaware of...
-
Uncategorized2 months agoSidewinder secures $137M to advance ‘precision’ ADCs
Backed by OrbiMed, Novartis’ venture arm and many other investors, the biotech is among those working on newer technology that could broaden the reach of antibody-drug...
-
Uncategorized2 months ago
PhRMA head Steve Ubl to step down, according to sources
Stephen Ubl, the leader of the drug industry’s powerful Washington, DC, lobbying group PhRMA, plans to step down, Endpoints News has learned from sources familiar with...
-
Uncategorized2 months ago
With 3 quick buyouts, Gilead leans into its latest transformation
On a conference call with analysts, Gilead walked through how a string of recent deals focused on cancer and autoimmune conditions could help a diversification plan...
-
Uncategorized2 months ago
Forecasting Protein Aggregation with an Improved Algorithm
A new, improved algorithm for studying protein aggregation could help biologics manufacturers design better-performing products with less experimental effort. The software, developed by scientists based in Barcelona,...
-
Uncategorized2 months agoActivist investor revives campaign to overhaul Novavax board
Shah Capital, which has agitated for change at the vaccine maker for years, is calling on fellow shareholders to end what it calls “dogmatic leadership” that’s...
-
Uncategorized2 months ago
Merck adjusts its vaccine supply deal in China; Soleno withdraws EU application
Plus, news about Novavax, ReAlta and AtaiBeckley: Merck adjusts China vaccine supply deal: The company and its distribution partner Zhifei have tweaked their agreement as Merck...
-
Uncategorized2 months agoSTAT+: Terns’ drug may not be as competitive as many initially thought
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I jinxed it...
-
Uncategorized2 months ago
Gilead takes another big swing at expanding beyond HIV
Gilead takes another big swing at expanding beyond HIV
Hantavirus One-Shot mRNA Vaccine Fully Protects in Syrian Hamster Model
SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines
